Kodu・Aktsiate loetelu・Novo Nordisk A-S (Class B)

Novo Nordisk A-S (Class B)

Suletud

255.7 2.08

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

255.3

Max

257.5

Põhinäitajad
By Trading Economics
Sissetulek	-28B 21B
Müük	-18B 78B
P/E Sektori keskmine	9.483 47.946
Aktsiakasum	6.18
Dividenditootlus	4.74
Kasumimarginaal	26.742
Töötajad	66,700
EBITDA	-31B 39B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+9.53% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	4.74% 2.27%
Järgmine tulemuste avaldamine	4. nov 2026

Turustatistika
By TradingEconomics
Turukapital	-267B 1.1T
Eelmine avamishind	253.62
Eelmine sulgemishind	255.7

Novo Nordisk A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. okt 2026, 23:51 UTC

Canada's Housing Starts Data Set for Release Amidst Weak Employment Figures, Forecasting 230K Units and Cautious Market Sentiment.

10. okt 2026, 23:41 UTC

Market Awaits NY Empire State Manufacturing Index Release Amid Cautious Optimism and Broader Economic Concerns on October 15, 2026.

10. okt 2026, 23:41 UTC

Philadelphia Fed Manufacturing Index for October 2026 set to release with optimistic growth forecast amid inflation concerns and upcoming earnings reports.

10. okt 2026, 23:41 UTC

Core Producer Prices Expected to Rise 0.3% in September, Amid Cautious Market Sentiment and Inflation Concerns Ahead of Key Economic Reports

10. okt 2026, 23:41 UTC

US Producer Price Index Expected to Rise 0.5% Amidst Deteriorating Consumer Confidence and Inflation Concerns Ahead of October Release

10. okt 2026, 23:31 UTC

Australia's upcoming employment data release on October 15 is crucial, following a significant decline in full-time jobs and amid cautious economic sentiment influenced by global market fluctuations.

10. okt 2026, 23:31 UTC

Australia's Unemployment Rate Expected to Rise to 4.6% in September, Sparking Concerns Over Labor Market Stability Amid Global Economic Volatility

10. okt 2026, 23:31 UTC

Australia's Employment Change Report on October 15 Expected to Show Job Growth Amid Global Labor Market Concerns.

10. okt 2026, 23:21 UTC

US CPI Release on October 14 Sparks Caution Among Investors Amid Declining Consumer Sentiment and Inflation Concerns

10. okt 2026, 23:21 UTC

U.S. CPI data release on October 14 expected to show inflation rise to 3.6%, amid declining consumer confidence and fears of Federal Reserve tightening ahead of midterm elections.

10. okt 2026, 23:21 UTC

Core Inflation Rate Release on October 14, 2026, Expected to Rise by 0.2%, Influencing Federal Reserve Interest Rate Decisions Amidst Cautious Market Sentiment and Consumer Concerns Over Rising Costs.

10. okt 2026, 23:21 UTC

U.S. Inflation Rate Expected to Rise 0.6% in September Amid Consumer Confidence Decline and Geopolitical Tensions, Influencing Federal Reserve Policy Discussions

10. okt 2026, 23:21 UTC

Market Anticipates CPI Release Amid Rising Inflation Concerns and Mixed Investor Sentiment

10. okt 2026, 23:21 UTC

Core Inflation Rate for September 2026 Expected to Rise Slightly to 2.5%, Heightening Market Caution Amidst Rising Consumer Sentiment and Geopolitical Tensions.

10. okt 2026, 23:11 UTC

Brazil's Retail Sales Data Release on October 15 Expected to Reveal Consumer Spending Trends Amid Cautious Market Sentiment.

10. okt 2026, 23:01 UTC

Macro News

The Dow Jones Index (US) is trading roughly flat in after-market hours amid concerns over semiconductor stocks and heightened geopolitical tensions.

10. okt 2026, 22:51 UTC

Japan's Machinery Orders MoM data for August, set to release on October 14, is expected to show a modest 2.5% growth amid mixed manufacturing sentiment and concerns over softening demand.

10. okt 2026, 22:51 UTC

Australia's NAB Business Confidence report set for October 13 reveals cautious market sentiment amid declining confidence and rising costs, raising concerns over economic stability.

10. okt 2026, 22:51 UTC

RBA Meeting Minutes on October 13, 2026, Expected to Influence Interest Rate Decisions Amid Inflation Concerns and Global Economic Factors.

10. okt 2026, 22:51 UTC

The Nikkei 225 Index is roughly flat in after-market trading, holding steady since Friday's close amid positive sentiment ahead of upcoming corporate earnings reports.

10. okt 2026, 22:41 UTC

Singapore's Q3 2026 GDP Growth Rate Release on October 14 Sparks Cautious Optimism Amid Economic Recovery Signs and Mixed Asian Market Sentiments.

10. okt 2026, 22:41 UTC

U.S. 30-Year Mortgage Rates Hit 7.49% Amid Rising Treasury Yields and Inflation Concerns, Forecasting Continued Upward Pressure on Housing Market Demand

10. okt 2026, 22:31 UTC

Brazil's Central Bank to Release Key Interest Rate Insights Amid Rising Inflation on October 13, 2026.

10. okt 2026, 22:21 UTC

South Korea's Unemployment Rate Release on October 15 Expected to Reflect Labor Market Resilience Amid Global Economic Pressures.

10. okt 2026, 22:01 UTC

Spain's Consumer Confidence Index set for October 13 release amid cautious sentiment due to inflation and geopolitical tensions.

10. okt 2026, 21:31 UTC

Italy's Balance of Trade data set for October 16, with a forecasted €7.5 billion surplus amid cautious sentiment following disappointing industrial production figures.

10. okt 2026, 21:31 UTC

UK Retail Sales Monitor YoY for September 2026 Expected to Show Modest 0.7% Increase Amid Cautious Consumer Sentiment and Inflation Concerns

10. okt 2026, 20:41 UTC

India's Inflation Rate YoY Release on October 12, 2026, Expected to Reflect Ongoing Energy Price Pressures Amid Optimistic Market Sentiment.

10. okt 2026, 20:31 UTC

API Crude Oil Stock Change Report on October 14, 2026, to Reflect Inventory Fluctuations Amid Geopolitical Tensions and Market Caution Ahead of Key Inflation Data.

10. okt 2026, 20:31 UTC

Fed Governor Barkin's Upcoming Speech Sparks Cautious Market Sentiment Amid Inflation Concerns and Key Economic Data Releases.

Võrdlus sarnastega

Hinnamuutus

Novo Nordisk A-S (Class B) Prognoos

Hinnasiht

By TipRanks

9.53% tõus

12 kuu keskmine prognoos

Keskmine 1,162.73 DKK 9.53%

Kõrge 1,550 DKK

Madal 720 DKK

Põhineb 11 Wall Streeti analüütiku instrumendi Novo Nordisk A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi Novo Nordisk A-S (Class B) aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Novo Nordisk A-S (Class B)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.